1. Researchers call out Gilead over diversity of remdesivir trials — Bristol-Myers commits $300M to combat racial disparities — Goldman predicts at least one coronavirus vaccine approval before the end of 2020 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Nevro

Anonymous board for Nevro


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    133
    Views:
    47,522
  2. anonymous
    Replies:
    8
    Views:
    3,174
  3. anonymous
    Replies:
    159
    Views:
    54,276
  4. anonymous
    Replies:
    17
    Views:
    1,895
  5. anonymous
    Replies:
    1
    Views:
    1,948
  6. anonymous
    Replies:
    0
    Views:
    1,681
  7. anonymous
    Replies:
    1
    Views:
    1,175
  8. anonymous
    Replies:
    11
    Views:
    4,241
  9. anonymous
    Replies:
    1
    Views:
    1,944
  10. anonymous
    Replies:
    0
    Views:
    1,633
  11. Anonymous
    Replies:
    36
    Views:
    13,426
  12. anonymous
    Replies:
    25
    Views:
    7,637
  13. Anonymous
    Replies:
    369
    Views:
    82,997
  14. anonymous
    Replies:
    3
    Views:
    2,715
  15. anonymous
    Replies:
    2
    Views:
    3,451
  16. anonymous
    Replies:
    2
    Views:
    2,237
  17. Anonymous
    Replies:
    0
    Views:
    2,011
  18. Anonymous
    Replies:
    3
    Views:
    3,959
  19. Anonymous
    Replies:
    0
    Views:
    2,784

Thread Display Options

Loading...